 |
Please excuse our appearance while we update this web page.
The Division of Thoracic Surgery is actively involved in clinical research. Patients have the opportunity to participate in a number of clinical trials that are designed to improve survival and quality of life for almost every stage of lung cancer. The Division also offers the newest treatment protocols for mesothelioma and esophageal cancer. The multi-institution trials are approved and funded by the National Cancer Institute. The Brigham and Women's Hospital also conducts studies that are designed by Division investigators and approved by the Hospital's Internal Scientific Review and Human Protection Committees. Through participation in these clinical trials, patients can access treatment options that involve the newest therapies, staging techniques, and multimodality treatment plans.
Clinical research is one of our highest priorities, because it provides data and offers the opportunitiy for comparing novel therapies to the standard of care.
For more information on these studies please refer to the contacts listed below.
Studies currently accruing patients within the Division include the following:
Comments about this website may be directed to: kzahner@partners.org
NOTICE: This email is not for medically related issues. Comments or concerns regarding patient-related care should be directed to the Thoracic Surgery Clinic at 617-732-6824.
©2010, Division of Thoracic Surgery at Brigham and Women's Hospital. All rights reserved.
Division of Thoracic Surgery
Brigham and Women's Hospital
75 Francis Street
Boston, MA 02115